Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Clinical Trials News Monitoring

Get by Email • RSS

Published on Nov 9, 2024

Linaclotide Effective for Functional Constipation in Children with Neurodevelopmental Disorders

Use of linaclotide (Linzess) offers significant benefits for relief of functional constipation among children with neurodevelopment disorders, according to new research. An analysis of the pivotal phase 3 trial supporting approval from the North American …

Source: HCPLive - Label Pending
Published on Nov 9, 2024

Therapeutic Potential of Neuroimmune Modulation in Treatment Paradigm of Relapsing Multiple Sclerosis

Relapsing multiple sclerosis (MS), a form of MS characterized by episodes of new or worsening neurological symptoms followed by periods of partial or complete recovery, has traditionally been treated with disease-modifying therapies (DMTs). These therapies …

Source: NeurologyLive - Neutral
Published on Nov 9, 2024

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in ...

BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new data highlighting the potential of ciforadenant, the Company’s adenosine A2A receptor …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Nov 9, 2024

GA therapies coming down the pike

Reviewed by Katherine Talcott, MD There is a great need for more effective treatments for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) to reduce individual and societal burdens.Clinicians currently have 2 FDA-approved drugs, …

Source: Modern Retina - Label Pending
Published on Nov 9, 2024

Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate ...

Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable Safety Profile in Phase 1 Solid Tumor Study …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on Nov 9, 2024

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit

Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin enrollment by end-of-year NOVATO, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- …

Distribution channels:
Published on Nov 9, 2024

Ocugen, Inc. (NASDAQ:OCGN) Q3 2024 Earnings Call Transcript

Ocugen, Inc. (NASDAQ:OCGN) Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good morning and welcome to Ocugen’s Third Quarter 2024 Financial Results and Business Update. Please note that this call is being recorded at this time. All …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2024 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2024 Earnings Call Transcript November 7, 2024 Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.34, expectations were $-1.37. Operator: Good morning and welcome to Intellia …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Skye Bioscience, Inc. (PNK:SKYE) Q3 2024 Earnings Call Transcript

Skye Bioscience, Inc. (PNK:SKYE) Q3 2024 Earnings Call Transcript November 7, 2024 Skye Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.25. Operator: Ladies and gentlemen, thank you for standing by. My name is …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript November 7, 2024 Cassava Sciences, Inc. beats earnings expectations. Reported EPS is $-0.58, expectations were $-1.37. Operator: Ladies and gentlemen, welcome to Cassava Sciences Report …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript November 7, 2024 Iovance Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27547, expectations were $-0.3. Operator: Thank you for standing by. My name is …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2024 Earnings Call Transcript

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2024 Earnings Call Transcript November 7, 2024 Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-1.22. Operator: Good day, everyone, and welcome …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2024 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good morning. My name is Aaron, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Ligand’s …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics’ Third Quarter 2024 Financial Results Conference Call. At this time, all participants …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript November 7, 2024 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.7, expectations were $0.06. Operator: Greetings and welcome to Rigel Pharmaceutical’s …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call Transcript November 7, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.18. Operator: Ladies and gentlemen, thank you for standing by …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript November 7, 2024 ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.13. Operator: Thank you for standing by. My name is Celine and I will be your …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

Imunon, Inc. (NASDAQ:IMNN) Q3 2024 Earnings Call Transcript

Imunon, Inc. (NASDAQ:IMNN) Q3 2024 Earnings Call Transcript November 7, 2024 Imunon, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.37. Operator: Hello everyone. Good morning. My name is Malone, and I will be your operator …

Source: Insider Monkey - Neutral
Published on Nov 9, 2024

This scientist treated her Stage 3 breast cancer, researchers warn against...

A 49-year-old scientist successfully treated her breast cancer by using a virus she grew in the lab. Her self-treatment sparked discussion about the ethics of self-experimentation. A case report published in Vaccines described the case as " …

Source: Mint - Neutral

07 days 21:10:43

Send 2 Free
Press Releases
Use them anytime within 12 months

Featured Releases

Got News to Share? · Submit · See All

Published on November 10, 2024 - 21:00 GMT

TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with ...

NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. (“Taro” …

Distribution channels: Consumer Goods, Law ...
Published on November 11, 2024 - 01:30 GMT

In-Depth Analysis Of The Global Intraocular Lens Market: Key Drivers, Trends, Opportunities, And Forecast 2024-2033

The Business Research Company’s Intraocular Lens Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, November 11, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Early Year- …

Distribution channels: Business & Economy, Electronics Industry ...

Published on November 8, 2024 - 22:40 GMT

Revolutionizing Prescription Management: Ironsail Pharma Launches Advanced Pharmacy Network Technology

New York, New York, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ironsail Pharma is excited to announce the launch of its innovative pharmacy network technology, designed to transform the prescription management process for healthcare providers. This comprehensive …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 8, 2024 - 07:23 GMT

U.S. 503B Compounding Pharmacies Market Future Business Opportunities 2024-2031: Atlas Pharmaceuticals, Empower Pharmacy

Drug compounding is the process of combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual patient. BURLINGAME, CA, UNITED STATES, November 7, 2024 /⁨EINPresswire.com⁩/ -- Latest Report, titled “U.S …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2024 - 18:40 GMT

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in ...

BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new data highlighting the potential of ciforadenant, the Company’s adenosine A2A receptor …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 8, 2024 - 12:58 GMT

Pharmaceutical Packaging Market Expected to hit a CAGR of 9.5% by 2032 Driven by Health Awareness & Advanced Packaging

"The growth in the Pharmaceutical Packaging Market propelled due to growing demand for safe & stem packaging types due to growing health awareness” AUSTIN, TX, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- The Pharmaceutical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 8, 2024 - 14:00 GMT

Paratek Pharmaceuticals Announces Positive Top-Line Data from Phase 2b Study of Oral Omadacycline (OMC) in ...

First randomized placebo-controlled trial in NTM abscessus Symptom-based endpoints showed favorable improvement in frequency and severity of the most common symptoms Microbiologic endpoints showed higher conversion to negative sputum culture, without …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 8, 2024 - 12:45 GMT

Pearson Medical Technologies Introduces m:Print Bar Code Labeling Software v4 for Pharmacy Drug Supply Chain Security ...

ALEXANDRIA, La., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Pearson Medical Technologies announces the international release of m:Print® Bar Code Labeling Software Version 4, a powerful new upgrade of its industry-leading pharmacy barcode label printing software. m …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 759,508,336 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 10/20/2024

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on November 11, 2024 - 01:30 GMT

In-Depth Analysis Of The Global Intraocular Lens Market: Key Drivers, Trends, Opportunities, And Forecast 2024-2033

The Business Research Company’s Intraocular Lens Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, November 11, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Early Year- …

Distribution channels: Business & Economy, Electronics Industry ...
Published on November 10, 2024 - 21:15 GMT

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA⁽¹⁾ and Revises Upwards ...

Total Company Revenue increased 14.7% to $461.1 million in the third quarter of 2024 from $402.0 million in the third quarter of 2023; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 34.3% to $16.4 million …

Distribution channels:
Published on November 10, 2024 - 12:26 GMT

KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment

RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) announced a significant advancement in stem cell science, securing a U.S. patent for an innovative method that holds promise for breast …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on November 9, 2024 - 13:00 GMT

A1C Drink Inc. Announces Start of Clinical Trials in Early 2025, Targeting a Breakthrough in Diabetes Management

The anticipated results could position A1C Drinks as a transformative leader in the diabetes, weight loss, and pre-diabetes markets. KANSAS CITY, MO, UNITED STATES, November 9, 2024 /⁨EINPresswire.com⁩/ -- A1C Drink, Inc. (www.a1cdrinks.com), a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on November 9, 2024 - 22:29 GMT

ALK indlicenserer rettigheder til neffy®, den første godkendte næsespray med adrenalin til akut behandling af allergiske ...

ALK (ALKB:DC / OMX: ALK B) har i dag annonceret, at selskabet har indgået en strategisk licensaftale med USA-baserede ARS Pharmaceuticals, Inc. (”ARS Pharma”) (NASDAQ: SPRY). Aftalen giver ALK eksklusive rettigheder til neffy® adrenalin-næsesprayen …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 9, 2024 - 22:29 GMT

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (...

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants ALK exclusive global rights to the neffy® adrenaline ( …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on November 9, 2024 - 10:00 GMT

Royal 4 Systems exhibirá las últimas soluciones en logística y automatización en Logistics & Automation 2024

Royal 4 Systems, proveedor líder de soluciones en logística y automatización, ha anunciado hoy su participación en la próxima feria Logistics & Automation 2024. MADRID, SPAIN, November 9, 2024 /⁨EINPresswire.com⁩/ -- Royal 4 Systems, proveedor …

Distribution channels: Automotive Industry, Business & Economy ...
Published on November 9, 2024 - 08:39 GMT

The Business Research Company: Five Reasons Why We’re Your Essential Partner for Market Insights

The Business Research Company's Business Research Solutions | The Business Research Company – Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, November 9, 2024 /⁨EINPresswire.com⁩/ -- The Business …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on November 9, 2024 - 08:00 GMT

Marzena Odorczuk, MD of Internal Medicine Of Totowa Awarded As 2024 NJ Top Doc

NJ Top Docs has reviewed and approved internal medicine specialist, Marzena Odorczuk, MD based on merit for 2024. TOTOWA, NJ, UNITED STATES, November 9, 2024 /⁨EINPresswire.com⁩/ -- Marzena Odorczuk, MD of Internal Medicine of Totowa has been …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 9, 2024 - 18:40 GMT

Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in ...

BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new data highlighting the potential of ciforadenant, the Company’s adenosine A2A receptor …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 9, 2024 - 18:30 GMT

Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate ...

Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable Safety Profile in Phase 1 Solid Tumor Study …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on November 9, 2024 - 18:00 GMT

Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in ...

Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity across all subgroups with injected and non-injected lesions responding with similar frequency, depth, duration, and kinetics Initial biomarker data shows increase in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on November 9, 2024 - 15:30 GMT

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit

Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin enrollment by end-of-year NOVATO, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- …

Distribution channels:
Published on November 9, 2024 - 00:15 GMT

Ourian Plastic Surgery Announces New Content for Abdominal Etching in West Los Angeles

Ourian Plastic Surgery is proud to announce new blog content for abdominal etching in the West Los Angeles region. BEVERLY HILLS, CA, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- Ourian Plastic Surgery, a best-in-class cosmetic surgery …

Distribution channels: Amusement, Gaming & Casino, Culture, Society & Lifestyle ...
Published on November 8, 2024 - 23:51 GMT

Shakira Millar Champions Compassion-Driven Entrepreneurship with Behavior Change LLC

Shakira Millar is the co-founder of Behavior Change LLC, based in Pembroke Pines, Florida. PEMBROKE PINES, FL, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- Entrepreneur and behavior therapist Shakira Millar is redefining what it means …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on November 8, 2024 - 23:04 GMT

Damp Lab and eLabNext partner to launch software for easy ordering and outsourcing of molecular biology services

BOSTON, MA, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- The Design, Automation, Manufacturing, and Processes (DAMP) Lab and eLabNext announced a formal partnership today to coincide with the kick-off of the International Workshop for …

Distribution channels: Business & Economy, Education ...
Published on November 8, 2024 - 20:47 GMT

Depo-Provera and Meningioma: Pathology Examination and Progesterone Receptor Expression

High progesterone receptor positivity linked to low-grade meningiomas, highlighting risks of Depo-Provera use SANTA BARBARA , CA, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- “High progesterone receptor positivity was linked to low …

Distribution channels: Business & Economy, Education ...
Published on November 8, 2024 - 20:13 GMT

InnoSoda® offers fiber-rich, slow-carb refreshment as a natural alternative to sugary and artificially sweetened sodas

A soda innovation from Denmark: InnoSoda® offers fiber, slow carbs, and a clean label as a natural alternative to sugary and artificially sweetened sodas. AARHUS, JUTLAND, DENMARK, November 8, 2024 /⁨EINPresswire.com⁩/ -- Danish bio- and foodtech …

Distribution channels: Banking, Finance & Investment Industry, Consumer Goods ...
Published on November 8, 2024 - 20:04 GMT

Karma Health Launches Medical Construction Group, Setting New Standards in Healthcare Facility Expansion Solutions

MIAMI BEACH, FL, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- Karma Health, a leading innovator in healthcare marketing and operational solutions, proudly announces the launch of its newest division, Medical Construction Group (MCG). …

Distribution channels: Banking, Finance & Investment Industry, Building & Construction Industry ...
Published on November 8, 2024 - 19:36 GMT

Internal Healthcare Group Launches Nationwide Referral Service for Senior Care Solutions

“Internal Healthcare Group launches to connect seniors with trusted care options across the U.S. Offering free referrals for home health and senior care.” FL, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- Internal Healthcare Group …

Distribution channels: Culture, Society & Lifestyle, Environment ...